Skip to main content
. Author manuscript; available in PMC: 2015 Jul 21.
Published in final edited form as: J Clin Oncol. 2008 Jun 10;26(17):2821–2827. doi: 10.1200/JCO.2007.15.2264

Fig. 3.

Fig. 3

Notch pathway blockade seems to preferentially deplete stem-like medulloblastoma cells, leaving behind better-differentiated cells no longer able to form tumor masses. Both differentiation and cell death are involved in loss of the putative cancer stem cell (CSC) subpopulation.